Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Related party payables | (49,632) | 5,293 |
| Net cash (used in) provided by operating activities | (47,987) | 91,227 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (38,872) | (35,992) |
| Acquisition of intangible assets | (85,000) | (5,100) |
| Deposits for future acquisition of property, plant and equipment | (20,580) | (4,632) |
| Proceeds from sale of property, plant and equipment | — | 1,379 |
| Net cash used in investing activities | (144,452) | (44,345) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s capex?
- Amneal Pharmaceuticals, Inc. (AMRX) reported capex of $30.7M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s capex changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s capex increased by 34.5% year-over-year, from $22.83M to $30.7M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s capex?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s capex has grown at a 10.1% compound annual growth rate (CAGR), from $47.73M to $70.06M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Amneal Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude